Macrophage membrane-camouflaged proanthocyanidin nano-modulators inhibit histone lactylation and target therapy for testicular ischemia-reperfusion injury

Le résumé fourni par la source

Testicular torsion-detorsion induces testicular ischemia–reperfusion injury (TIRI), which is associated with excessive reactive oxygen species (ROS) generation. Proanthocyanidin (PC), a potent organic antioxidant, can inhibit oxidative stress. However, its inherent limitations, including poor targeting, short circulation time, and low membrane permeability, hinder its therapeutic efficacy. To overcome these limitations, a macrophage membrane-coated chitosan/hyaluronic acid (MM-CH) is developed as a biocompatible nanocarrier for encapsulating PC. Retaining critical macrophage membrane proteins, this biomimetic nanotherapeutic (MM-PC-CH) prolongs circulation and enhances active targeting to the injured testis. MM-PC-CH was effectively internalized by Sertoli cells. The activities of SOD, CAT and MDA, as well as the levels of IL-6, TNF-α and IL-10, apoptosis by flow cytometry and TUNEL assay were evaluated. The results demonstrated significant antioxidant, anti-inflammatory and anti-apoptotic effects, as well as inhibition of lactate levels. In vivo evaluations confirm that injected MM-PC-CH specifically accumulates in the injured testis, providing robust testicular protection and effectively alleviating TIRI. This study presents a promising biomimetic nanotherapy for alleviating testicular torsion by enhancing the targeted delivery of proanthocyanidin, providing an innovative strategy for precise treatment of various reproductive diseases with clinical translational value.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.